Latest information on COVID-19

Division of Oncology

in the Department of Medicine

Welcome to the Division of Oncology, a center of excellence in patient care, medical education, and state-of-the-art research. Cancer is a major public health problem and it is also an exciting challenge for discovery and innovation. 

Message from the Chief

A welcome message from the the Division of Oncology's Chief, Dr. Heather Wakelee.

Open Positions

The Division of Oncology is seeking qualified faculty for several open positions.  Successful applicants must hold an MD or MD/PhD degree and be board-certified or board-eligible in Medical Oncology, and have a history of significant peer-reviewed funding. 

Our Mission

  • To engage in research to create the future of cancer care
  • To provide the best in care for cancer patients
  • To train physicians for careers in academic medicine and research



We welcome three new Stanford Oncology faculty!

Dr. Jennifer Caswell-Jin received her MD at Harvard University and completed fellowship training in medical oncology at Stanford.   Dr. Caswell-Jin specializes in treating breast cancer; she transitions in her role on the Breast Oncology team to Assistant Professor in the MCL in April 2021.  She has expertise in breast cancer genomics and computational biology, and her research aims to perform in-depth characterization of tumors to allow optimization and personalization of treatment approaches for each tumor and each patient.

Dr. Tanya Gupta will be joining the faculty in April 2021 as a Clinical Instructor in the CE line with a clinical focus on breast oncology. Dr. Gupta completed her training in internal medicine and oncology at Stanford.  Her faculty practice will be predominantly at the Cancer Center South Bay location where she will be helping to develop and support the clinical trial research program, with a particular emphasis on breast cancer clinical trials. In addition to her role at CCSB she will maintain a presence on the Palo Alto campus including ongoing collaborations with her mentor Melinda Telli.

Dr. David Kurtz earned his MD degree at Mayo Medical School and completed his fellowship in Oncology at Stanford while earning a PhD in Bioengineering.  He transitions his role on the Lymphoma team to Assistant Professor in the MCL in April 2021.   Dr. Kurtz is studying translational genomics with an emphasis on lymphomas and other hematologic cancers. His research utilizes a combination of computational approaches, genomics, and molecular biology to develop and apply new tools to study cancers using both tissue-based and liquid biopsies.

We are delighted to welcome the newest members of our Division faculty.